Denyan Mansuroğlu
Research Subjects
Research Interests
Denyan Mansuroğlu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Kaan Kırali
Department of Cardio-Vascular Surgery, Koşuyolu High Specialization Training & Research Hospital, Kartal, İstanbul, Türkiye (Drs Hakan Hançer, Yiğit, Özgür, Gürel, and Kırali)
4 shared publications Cevat Yakut
Department of Cardiovascular Surgery, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
3 shared publicationsGokhan Ipek
Cardiology and Cardiovascular Surgery Clinics
3 shared publications- Murat Sezgin
Department of Cardiovascular Surgery, Tunceli State Hospital, Tunceli, Turkey
3 shared publications - Akin Izgi
Kosuyolu Heart and Research Hospital, Kadikoy, Istanbul, Turkey
2 shared publications Ali Cevat Tanalp
Kosuyolu Heart and Research Hospital
2 shared publications
Latest Publications
- 1 August 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101, S126
Journey from Bonsai Dependent Marginal Donor to a Happy Ending
As the prevelance of end stage heart failure increases clinicians are left without enough allografts to meet the growing need for heart transplantation.[1] This incompatible difference between the number of heart failure patients and the supply of suitable organs for transplant has increased the use of marginal donor hearts.[2][3] Reduced left ventricular ejection fraction in the donor heart has traditionally been a significant predictor of graft non utilization. However, there is enough evidence to accept that some donor hearts that do not initially meet optimum transplant criteria may be utilized with good results.[4] In February 2017 while we hospitalized a 44 year old male patient with end stage heart failure we have been informed about a 26 year old male patient who was previously using a synthetic Cannabinoid (Bonsai)[6][7] with no other known medical history. We learned that he had fallen from a balcony after taking the drug and sustained critical head injuries. After a brief period in the ICU he becomes haemodynamically unstable with no response to inotropic agents.[5] After brain death testing confirmed an echocardiogram is performed and reported as normal. In the course of harvesting mild left ventricular hypokinesia was noted. But as the final decision was given: the heart was arrested, preserved and was transplanted to the recipient. After the completion of the anastomoses of the allograft; heart started to beat spontaneously. However, the transesophageal echocardiography performed during the transplantation showed a bilateral ventricular dysfunction. The patient was supported by inotropes and central venoarterial extracorporeal membrane oxygenation (ECMO) when leaving the operating room. Patient was extubated and weaned from ECMO and decanulated on postoperative day 4. After extubation, a resistant atrial tachycardia was added to the condition in the early postoperative period with no response to medical therapy, requiring DC cardioversion. Than the patient immediately became haemodynamically stable; left and right ventricle functions on echocardiography were improved and he was able to be discharged 34 days post transplantation. He is symptom free at 1month follow up with normal cardiac function. Acute severe left ventricular dysfunction in cardiac allograft occurring in association with severe neurological injury and drug addiction; maintained well after appropriate medical therapy. 1. Khush KK, Zaroff JG, Nguyen J, Menza R, Goldstein BA. National Decline in Donor Heart Utilization with Regional Variability: 1995‐2010. Am J Transplant 2015;15(3):642–649. 2. Lietz K, John R, Mancini DM, Edwards NM. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list: Implications for donor selection criteria. J Am Coll Cardiol 2004;43(9):1553–1561. 3. Forni A, Luciani GB, Chiominto B, Pizzuti M, Mazzucco A, Faggian G. Results with expanded donor acceptance criteria in heart transplantation. Transplant Proc. 2011;43(4):953–959. 4. Lima B, Rajagopal K, Petersen RP, et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1 Suppl): I27-32. 5.Berman M, Ali A, Ashley E, Freed D, Clarke K, Tsui S, et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2010 Sep;29(9):957–65. PubMed PMID: 20627624. 6. Ayhan H, Aslan AN, Süygün H, Durmaz T. [Bonsai induced acute myocardial infarction]. Turk Kardiyol Dern Ars. 2014 Sep;42(6):560–3. 7. Köklü E, Yüksel İÖ, Bayar N, Üreyen ÇM, Arslan Ş. A new cause of silent myocardial infarction: Bonsai. Anadolu Kardiyol Derg. 2015 Jan;15(1):69–70.
- 1 August 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101, S126
Journey from Bonsai Dependent Marginal Donor to a Happy Ending
As the prevelance of end stage heart failure increases clinicians are left without enough allografts to meet the growing need for heart transplantation.[1] This incompatible difference between the number of heart failure patients and the supply of suitable organs for transplant has increased the use of marginal donor hearts.[2][3] Reduced left ventricular ejection fraction in the donor heart has traditionally been a significant predictor of graft non utilization. However, there is enough evidence to accept that some donor hearts that do not initially meet optimum transplant criteria may be utilized with good results.[4] In February 2017 while we hospitalized a 44 year old male patient with end stage heart failure we have been informed about a 26 year old male patient who was previously using a synthetic Cannabinoid (Bonsai)[6][7] with no other known medical history. We learned that he had fallen from a balcony after taking the drug and sustained critical head injuries. After a brief period in the ICU he becomes haemodynamically unstable with no response to inotropic agents.[5] After brain death testing confirmed an echocardiogram is performed and reported as normal. In the course of harvesting mild left ventricular hypokinesia was noted. But as the final decision was given: the heart was arrested, preserved and was transplanted to the recipient. After the completion of the anastomoses of the allograft; heart started to beat spontaneously. However, the transesophageal echocardiography performed during the transplantation showed a bilateral ventricular dysfunction. The patient was supported by inotropes and central venoarterial extracorporeal membrane oxygenation (ECMO) when leaving the operating room. Patient was extubated and weaned from ECMO and decanulated on postoperative day 4. After extubation, a resistant atrial tachycardia was added to the condition in the early postoperative period with no response to medical therapy, requiring DC cardioversion. Than the patient immediately became haemodynamically stable; left and right ventricle functions on echocardiography were improved and he was able to be discharged 34 days post transplantation. He is symptom free at 1month follow up with normal cardiac function. Acute severe left ventricular dysfunction in cardiac allograft occurring in association with severe neurological injury and drug addiction; maintained well after appropriate medical therapy. 1. Khush KK, Zaroff JG, Nguyen J, Menza R, Goldstein BA. National Decline in Donor Heart Utilization with Regional Variability: 1995‐2010. Am J Transplant 2015;15(3):642–649. 2. Lietz K, John R, Mancini DM, Edwards NM. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list: Implications for donor selection criteria. J Am Coll Cardiol 2004;43(9):1553–1561. 3. Forni A, Luciani GB, Chiominto B, Pizzuti M, Mazzucco A, Faggian G. Results with expanded donor acceptance criteria in heart transplantation. Transplant Proc. 2011;43(4):953–959. 4. Lima B, Rajagopal K, Petersen RP, et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1 Suppl): I27-32. 5.Berman M, Ali A, Ashley E, Freed D, Clarke K, Tsui S, et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2010 Sep;29(9):957–65. PubMed PMID: 20627624. 6. Ayhan H, Aslan AN, Süygün H, Durmaz T. [Bonsai induced acute myocardial infarction]. Turk Kardiyol Dern Ars. 2014 Sep;42(6):560–3. 7. Köklü E, Yüksel İÖ, Bayar N, Üreyen ÇM, Arslan Ş. A new cause of silent myocardial infarction: Bonsai. Anadolu Kardiyol Derg. 2015 Jan;15(1):69–70.
- 1 October 2008
- Vol. 8 (5) , 360-6
Factors associated with long-term survival following cardiac transplantation.
By improving short and long-term survivals, cardiac transplantation would be a more realistic curative treatment modality. The aim of this study was to evaluate factors associated with the long-term survival following cardiac transplantations in our center. Forty-four patients were operated on cardiac transplantation between 1989 and November 2006. The study was designed in a retrospective manner and all data were collected from hospital records. Our study population consisted of 16 patients (Group A) who survived >1 month, but died <2 years after cardiac transplantation and 17 patients (Group B) who survived more than 2 years. All patients had triple immunosuppressive therapy (cyclosporine, azathioprine, corticosteroid). Statistical analyses were performed using Fischer's exact and Mann Whitney U tests, and multivariate regression analysis. Survival was analyzed using Cox proportional hazard regression analysis. Group B patients had lower pre-transplant creatinine levels (0.93+/-0.28 mg/dl vs. 1.16+/-0.21 mg/dl, p=0.033) younger donor age (24.5+/-6.3 years vs. 30.1+/-8.1 years, p=0.017) and more male donors (82.3% vs. 50%, p=0.05) as compared with Group A patients. The perioperative and follow-up analysis showed that patients with long-term survival had shorter ischemic time (141.5+/-33.2 min vs. 182.5+/-49.2 min, p=0.007), aortic cross clamp time (65.9+/-10.2 min vs. 83.6+/-7.9 min, p<0.001), less amount of blood transfusion (3.4+/-1.6 units vs. 5.0+/-1.5 units, p=0.01), better NYHA status after operation (1+/-0 vs. 1.63+/-0.72, p=0.014) and less frequent acute rejection episodes (11.8% vs. 68.8%, p<0.001) than those with short-term survival after operation. Cox proportional hazard regression analysis showed higher preoperative creatinine level (HR=42.6, 95% CI 4.67-388.21, p=0.001), acute rejection (HR=4.45, 95% 1.44-13.77, p=0.01), early postoperative functional status (HR=4.84, 95% CI 1.9-12.27, p=0.001) and unsatisfactory rejection surveillance protocol in the first 6 months after transplantation (HR=0.2, 95% CI 0.07-0.67, p=0.008) were prominent factors associated with the long-term survival. The availability of the donor hearts from younger male donors with the shortest ischemic times is identified as the most significant factor improving long-term survival. The main strategy in cardiac transplantation should be shortening ischemic times and applying strict postoperative follow-up.
- 1 October 2008
- Vol. 8 (5) , 360-6
Factors associated with long-term survival following cardiac transplantation.
By improving short and long-term survivals, cardiac transplantation would be a more realistic curative treatment modality. The aim of this study was to evaluate factors associated with the long-term survival following cardiac transplantations in our center. Forty-four patients were operated on cardiac transplantation between 1989 and November 2006. The study was designed in a retrospective manner and all data were collected from hospital records. Our study population consisted of 16 patients (Group A) who survived >1 month, but died <2 years after cardiac transplantation and 17 patients (Group B) who survived more than 2 years. All patients had triple immunosuppressive therapy (cyclosporine, azathioprine, corticosteroid). Statistical analyses were performed using Fischer's exact and Mann Whitney U tests, and multivariate regression analysis. Survival was analyzed using Cox proportional hazard regression analysis. Group B patients had lower pre-transplant creatinine levels (0.93+/-0.28 mg/dl vs. 1.16+/-0.21 mg/dl, p=0.033) younger donor age (24.5+/-6.3 years vs. 30.1+/-8.1 years, p=0.017) and more male donors (82.3% vs. 50%, p=0.05) as compared with Group A patients. The perioperative and follow-up analysis showed that patients with long-term survival had shorter ischemic time (141.5+/-33.2 min vs. 182.5+/-49.2 min, p=0.007), aortic cross clamp time (65.9+/-10.2 min vs. 83.6+/-7.9 min, p<0.001), less amount of blood transfusion (3.4+/-1.6 units vs. 5.0+/-1.5 units, p=0.01), better NYHA status after operation (1+/-0 vs. 1.63+/-0.72, p=0.014) and less frequent acute rejection episodes (11.8% vs. 68.8%, p<0.001) than those with short-term survival after operation. Cox proportional hazard regression analysis showed higher preoperative creatinine level (HR=42.6, 95% CI 4.67-388.21, p=0.001), acute rejection (HR=4.45, 95% 1.44-13.77, p=0.01), early postoperative functional status (HR=4.84, 95% CI 1.9-12.27, p=0.001) and unsatisfactory rejection surveillance protocol in the first 6 months after transplantation (HR=0.2, 95% CI 0.07-0.67, p=0.008) were prominent factors associated with the long-term survival. The availability of the donor hearts from younger male donors with the shortest ischemic times is identified as the most significant factor improving long-term survival. The main strategy in cardiac transplantation should be shortening ischemic times and applying strict postoperative follow-up.
- 7 July 2006
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 21 (5) , 449-453
Does Aortic Root Enlargement Impair the Outcome of Patients With Small Aortic Root?
Background: Posterior root enlargement procedures provide the implantation of suitable-sized prosthetic valves in patients with a small aortic root to prevent a high postoperative transvalvular gradient. The aim of this study was to evaluate long-term results of the posterior root enlargement. Methods: Between 1985 and 2002, 124 patients underwent aortic valve replacement with a posterior root enlargement. The main indication was a small aortic valve orifice area to patient body surface area (indexed valve area < 0.85 cm2/m2). Fifty-four (44%) patients were male, and 70 (56%) were female with a mean age 39.1 ± 14.3 years. Indications for operation were severe calcified aortic valve stenosis (37.1%), severe aortic insufficiency (25.8%), or combination (37.1%). Seventy-five (60%) patients received double-valve replacement. A pericardial patch was used in 100 patients (80.6%) and a Dacron patch was used in 24 patients. Results: Operative mortality was 6.4% (8 patients). The causes of hospital mortality were low cardiac output syndrome (LCOS) (in 6 patients), cerebrovascular events (in 1 patient) and multiple organ failure (in 1 patient). Multivariate analysis demonstrated concomitant coronary revascularization to be a significant (p = 0.03) predictor for early mortality. There were six (5.4%) late deaths. Cox proportional hazards regression analysis demonstrated LCOS (p = 0.013) and infective endocarditis (p = 0.003) to be significant predictors for late mortality. Atrioventricular block required a permanent pacemaker was observed in 4 patients (3.2%). Conclusions: Posterior aortic root enlargement techniques can be easily applied without additional risks. Long-term survival and freedoms from valve-related complications are satisfactory.
- 7 July 2006
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 21 (5) , 449-453
Does Aortic Root Enlargement Impair the Outcome of Patients With Small Aortic Root?
Background: Posterior root enlargement procedures provide the implantation of suitable-sized prosthetic valves in patients with a small aortic root to prevent a high postoperative transvalvular gradient. The aim of this study was to evaluate long-term results of the posterior root enlargement. Methods: Between 1985 and 2002, 124 patients underwent aortic valve replacement with a posterior root enlargement. The main indication was a small aortic valve orifice area to patient body surface area (indexed valve area < 0.85 cm2/m2). Fifty-four (44%) patients were male, and 70 (56%) were female with a mean age 39.1 ± 14.3 years. Indications for operation were severe calcified aortic valve stenosis (37.1%), severe aortic insufficiency (25.8%), or combination (37.1%). Seventy-five (60%) patients received double-valve replacement. A pericardial patch was used in 100 patients (80.6%) and a Dacron patch was used in 24 patients. Results: Operative mortality was 6.4% (8 patients). The causes of hospital mortality were low cardiac output syndrome (LCOS) (in 6 patients), cerebrovascular events (in 1 patient) and multiple organ failure (in 1 patient). Multivariate analysis demonstrated concomitant coronary revascularization to be a significant (p = 0.03) predictor for early mortality. There were six (5.4%) late deaths. Cox proportional hazards regression analysis demonstrated LCOS (p = 0.013) and infective endocarditis (p = 0.003) to be significant predictors for late mortality. Atrioventricular block required a permanent pacemaker was observed in 4 patients (3.2%). Conclusions: Posterior aortic root enlargement techniques can be easily applied without additional risks. Long-term survival and freedoms from valve-related complications are satisfactory.
- 1 January 2005
- Published by Wiley in Echocardiography
- Vol. 22 (1) , 49-50
Giant Cystic Left Atrial Myxoma as a Cause of Secondary Pulmonary Hypertension
- 1 January 2005
- Published by Wiley in Echocardiography
- Vol. 22 (1) , 49-50
Giant Cystic Left Atrial Myxoma as a Cause of Secondary Pulmonary Hypertension
- 1 November 2004
- Vol. 13 (6) , 925-6
Cystic subaortic discrete membrane in an elderly woman.
A discrete subaortic membrane is an uncommon cause of left ventricular outflow tract (LVOT) obstruction in patients of advanced age. Here, a significant LVOT obstruction caused by a discrete membrane is reported in a 64-year-old woman. On echocardiographic examination the membrane had a cystic appearance. To the present authors' knowledge, this is the first reported case of a cystic subaortic membrane.
- 1 November 2004
- Vol. 13 (6) , 925-6
Cystic subaortic discrete membrane in an elderly woman.
A discrete subaortic membrane is an uncommon cause of left ventricular outflow tract (LVOT) obstruction in patients of advanced age. Here, a significant LVOT obstruction caused by a discrete membrane is reported in a 64-year-old woman. On echocardiographic examination the membrane had a cystic appearance. To the present authors' knowledge, this is the first reported case of a cystic subaortic membrane.
- 1 September 2004
- Vol. 4 (3) , 266-7
Surgical treatment of the atrial septal aneurysms with concomitant cardiovascular abnormalities.
- 1 September 2004
- Vol. 4 (3) , 266-7
Surgical treatment of the atrial septal aneurysms with concomitant cardiovascular abnormalities.
- 1 December 2003
- Vol. 3 (4) , 374-5
[Tricuspid valve endocarditis mimicking cardiac tumor].
- Open Access
- 1 December 2003
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 2 (4) , 653-656
Surgical treatment for late postoperative radial artery graft spasm
Hemodynamic instability due to late postoperative radial artery spasm is a rare phenomenon. This entity developed in our patient who was operated on for severe left main coronary artery stenosis with a dominant circumflex artery. The spasm could not be relieved with intraluminal vasodilator therapy, and the patient underwent reoperation using a saphenous vein graft-anastomosed distal to radial artery.
- 1 December 2003
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 2 (4) , 653-656
Open AccessSurgical treatment for late postoperative radial artery graft spasm
Hemodynamic instability due to late postoperative radial artery spasm is a rare phenomenon. This entity developed in our patient who was operated on for severe left main coronary artery stenosis with a dominant circumflex artery. The spasm could not be relieved with intraluminal vasodilator therapy, and the patient underwent reoperation using a saphenous vein graft-anastomosed distal to radial artery.
- 1 September 2003
- Vol. 3 (3) , 216-20
[Surgical treatment of peripheral vascular injuries after cardiac catheterization].
Diagnostic and therapeutic cardiac interventions have being performed in expanding numbers during last years. Forty-two cases with peripheral vascular injuries requiring surgical therapy after 64.911 cardiac interventions in our center between 1985 and 2002 were evaluated retrospectively. Thirty-three of vascular injuries (78.6%) occurred after angiography/catheterization, and the remaining vascular injuries (21.4%) occurred after angioplasty/stent procedures. There were 12 female (28.6%) and 30 male (71.4%). The mean age was 51.3+/-4.1 years. The localization of the arterial injuries were femoral region in 37 cases (88.1%) and brachial region in 5 cases (11.9%). The complications were recorded as arterial thrombosis in 19 cases, pseudoaneurysm in 14 cases, hematoma in 5 cases, arteriovenous fistula in 2 cases, deformed stent stuck in 2 cases. Arterial injuries were treated by performing embolectomy in 16 cases, embolectomy and saphenous patch plasty in 3 cases, resection of pseudoaneurysm and PTFE patch plasty in 1 case, draining of hematoma and primary repair in 5 cases, primary repair of femoral arteriovenous fistula in 2 cases and removal of the deformed stent from femoral artery in 2 cases. The incidence of vascular complications was significantly higher in brachial interventions when compared with femoral interventions (p<0.0001). The postoperative morbidity was found as 14.3% in our cases. The early diagnosis and treatment are very important in peripheral vascular complications after cardiac interventions; otherwise, delay can cause loss of related extremity.
- 1 September 2003
- Vol. 3 (3) , 216-20
[Surgical treatment of peripheral vascular injuries after cardiac catheterization].
Diagnostic and therapeutic cardiac interventions have being performed in expanding numbers during last years. Forty-two cases with peripheral vascular injuries requiring surgical therapy after 64.911 cardiac interventions in our center between 1985 and 2002 were evaluated retrospectively. Thirty-three of vascular injuries (78.6%) occurred after angiography/catheterization, and the remaining vascular injuries (21.4%) occurred after angioplasty/stent procedures. There were 12 female (28.6%) and 30 male (71.4%). The mean age was 51.3+/-4.1 years. The localization of the arterial injuries were femoral region in 37 cases (88.1%) and brachial region in 5 cases (11.9%). The complications were recorded as arterial thrombosis in 19 cases, pseudoaneurysm in 14 cases, hematoma in 5 cases, arteriovenous fistula in 2 cases, deformed stent stuck in 2 cases. Arterial injuries were treated by performing embolectomy in 16 cases, embolectomy and saphenous patch plasty in 3 cases, resection of pseudoaneurysm and PTFE patch plasty in 1 case, draining of hematoma and primary repair in 5 cases, primary repair of femoral arteriovenous fistula in 2 cases and removal of the deformed stent from femoral artery in 2 cases. The incidence of vascular complications was significantly higher in brachial interventions when compared with femoral interventions (p<0.0001). The postoperative morbidity was found as 14.3% in our cases. The early diagnosis and treatment are very important in peripheral vascular complications after cardiac interventions; otherwise, delay can cause loss of related extremity.